We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WEX:NYSEWEX Inc. Analysis

Data as of 2026-08-08 - not real-time

$185.22

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

WEX Inc. is priced at $185.22 and its moving averages line up in bullish order, the shorter sitting above the longer. Over a rolling month the price has gained 39.2%. Relative strength is 67.3 — approaching overbought — and the MACD signal is bullish. Recent trading has carved out support near $152.66 and resistance around $192.37.
Multiples put this in fair territory: 18.9 times earnings against the sector's 36.1. Revenue is growing at 14.2% on a 12.6% profit margin.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 42.0%, a beta of 0.53 and a maximum drawdown of 31.4%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 5/10.

Top Market Events

Updated Jul 22, 2026 0 PORTLAND, Maine-- BUSINESS WIRE --Jul 22, 2026-- WEX NYSE: WEX , a global leader in intelligent...Payment solutions provider WEX NYSE:WEX reported Q2 CY2026 results , with sales up 14.WEX Inc WEX reports a 14.2% revenue increase and leverages AI for efficiency, while navigating economic challenges and...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 153.72
  • MACD momentum is positive

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 18.9 versus sector average of 36.1
  • Trading above the 200-day average of 153.72

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 18.9 versus sector average of 36.1
  • Revenue growth of +14.2%
  • Return on equity of 30.2%

Key Metrics & Analysis

Financial Health

Revenue Growth14.20%
Profit Margin12.56%
P/E Ratio18.9
ROE30.19%
ROA2.89%
Debt/Equity398.42
P/B Ratio4.7
Op. Cash Flow$262.9M
Free Cash Flow$1.3B
Industry P/E36.1

Technical Analysis

TrendBullish
RSI67.3
Support$152.66
Resistance$192.37
MA 20$174.58
MA 50$154.75
MA 200$153.72
MACDBullish
VolumeStable
Fear & Greed Index94.82

Valuation

Fair Value$923.76
Target Price$190.30
Upside/Downside2.74%
GradeFair
TypeGrowth

Risk Assessment

Beta0.53
Volatility41.97%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.